The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Rhinalgia 4
SANDOSTATIN LAR DEPOT Sensation of foreign body 4
SANDOSTATIN LAR DEPOT Shock 4
SANDOSTATIN LAR DEPOT Sinus congestion 4
SANDOSTATIN LAR DEPOT Skin exfoliation 4
SANDOSTATIN LAR DEPOT Sneezing 4
SANDOSTATIN LAR DEPOT Spinal cord neoplasm 4
SANDOSTATIN LAR DEPOT Staphylococcal infection 4
SANDOSTATIN LAR DEPOT Tearfulness 4
SANDOSTATIN LAR DEPOT Testicular disorder 4
SANDOSTATIN LAR DEPOT Thirst 4
SANDOSTATIN LAR DEPOT Tooth abscess 4
SANDOSTATIN LAR DEPOT Tumour marker increased 4
SANDOSTATIN LAR DEPOT Urinary retention 4
SANDOSTATIN LAR DEPOT Urine abnormality 4
SANDOSTATIN LAR DEPOT Uterine cancer 4
SANDOSTATIN LAR DEPOT Venous occlusion 4
SANDOSTATIN LAR DEPOT Weight loss poor 4
SANDOSTATIN LAR DEPOT Wound infection 4
SANDOSTATIN Angina pectoris 3

Total Records: 2,045     Number of Pages: 103